Unicycive Therapeutics UNCY
NASDAQ UNCY
$3.89 -0.05 (-1.27%)
At close: Oct 23, 2026 · 4:00 PM EDT

Unicycive Therapeutics (UNCY) Selling, General & Administrative (2020 - 2026)

Updated

Unicycive Therapeutics' Selling, General & Administrative was $7.35 million in Q2 2026, up 41.0% from $5.21 million a year earlier and up 7.6% from the prior quarter.

Analysis

Unicycive Therapeutics (UNCY) Selling, General & Administrative (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, Unicycive Therapeutics' Selling, General & Administrative was $23.53 million through Jun 30, 2026, up 29.2% year-over-year; for FY2025, it came in at $20.4 million, up 68.5% from FY2024.

  • Selling, General & Administrative has now increased for five consecutive years, with a five-year compound annual growth rate of 82.6% (FY2020 to FY2025).
  • In earlier years, Selling, General & Administrative was $12.1 million in FY2024 (+41.6%), $8.55 million in FY2023 (+30.2%), $6.57 million in FY2022 (+126.7%) and $2.9 million in FY2021 (+188.3%).
  • The Q2 2026 figure marks the highest quarterly Selling, General & Administrative in data going back to Q2 2020.
  • Compared with a year earlier, Selling, General & Administrative has increased for 21 straight quarters, with growth averaging 60.7% over the last eight quarters.
  • Over the past five years, the year-over-year growth in Selling, General & Administrative ranged from 6.8% (Q4 2022) to 521.0% (Q2 2022).
  • Per Business Quant data, UNCY's Selling, General & Administrative in the three quarters before Q2 2026 was $6.83 million (Q1 2026), $4.97 million (Q4 2025) and $4.38 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 6.29 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 3.63 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 3.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 5.65 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 1.92 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 3.41 Bn
10 Unicycive Therapeutics 104.44 Mn -95.54 Mn - 7.35 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.35 Mn
Mar 31, 2026 6.83 Mn
Dec 31, 2025 4.97 Mn
Sep 30, 2025 4.38 Mn
Jun 30, 2025 5.21 Mn
Mar 31, 2025 5.82 Mn
Dec 31, 2024 3.97 Mn
Sep 30, 2024 3.21 Mn
Jun 30, 2024 2.53 Mn
Mar 31, 2024 2.39 Mn
Dec 31, 2023 2.08 Mn
Sep 30, 2023 2.57 Mn
Jun 30, 2023 2.06 Mn
Mar 31, 2023 1.85 Mn
Dec 31, 2022 1.49 Mn
Sep 30, 2022 1.70 Mn
Jun 30, 2022 1.78 Mn
Mar 31, 2022 1.60 Mn
Dec 31, 2021 1.39 Mn
Sep 30, 2021 939,000.00
API Access

Unicycive Therapeutics Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=UNCY&period=max&api_key=YOUR_API_KEY